About: Novimmune

An Entity of Type: Thing, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Novimmune is a privately held Swiss pharmaceutical development company focusing on monoclonal antibody therapies for treatment of immune-related diseases. The company was founded in 1998. Novimmune has six publicly disclosed drug in their pipeline: No drugs have been approved yet.

Property Value
dbo:abstract
  • Novimmune is a privately held Swiss pharmaceutical development company focusing on monoclonal antibody therapies for treatment of immune-related diseases. The company was founded in 1998. Novimmune has six publicly disclosed drug in their pipeline: * , an anti-TLR4 antibody being developed in partnership with Genentech. A phase I clinical trial was completed in 2014 and phase II trials are expected to begin in early 2017. * , an anti-CD3ε antibody being developed in partnership with . Phase II trials in patients with Crohn's disease and transplant rejection finished in 2008 and 2009, respectively. * NI-0501, an anti-IFNγ antibody, is in development for hemophagocytic lymphohistiocytosis. A phase II/III trial began in 2013 and is ongoing. The FDA awarded breakthrough status to the drug in 2016. * , an anti-IL17 drug being developed in partnership with Genentech for inflammatory and auto-immune diseases. * , an anti-CD47, anti-CD19 bispecific antibody in development for treatment of B-cell hematological cancers. * , an anti-CD47, anti-mesothelin bispecific antibody in the preclinical phase of development for treatment of solid tumors. No drugs have been approved yet. (en)
dbo:wikiPageID
  • 52839613 (xsd:integer)
dbo:wikiPageLength
  • 3890 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1118361546 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dcterms:subject
rdfs:comment
  • Novimmune is a privately held Swiss pharmaceutical development company focusing on monoclonal antibody therapies for treatment of immune-related diseases. The company was founded in 1998. Novimmune has six publicly disclosed drug in their pipeline: No drugs have been approved yet. (en)
rdfs:label
  • Novimmune (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy